Phase 2 Trial of Daratumumab, Ixazomib, Lenalidomide and Modified Dose Dexamethasone in Patients with Newly Diagnosed Multiple MyelomaPrashant Kapoor, Shaji Kumar, Eric Wolfe et al.|Blood|2019Cited by 13
Phase 2 Trial of Ixazomib, Lenalidomide, Dexamethasone and Daratumumab in Patients with Newly Diagnosed Multiple MyelomaShaji Kumar, Eric Wolfe, Prashant Kapoor et al.|Blood|2018Cited by 12